RTX (RTX) Hits A DeepStrike Milestone, Is The Backlog Story Fully Priced? - Simply Wall St
RTX's Raytheon unit completed a third successful DeepStrike JR3 flight test for the U.S. Army's Joint Reduced Range Rocket program, as the company's shares trade at $198.58 with mixed recent performance.
RTX's defense and aerospace division is back in the spotlight following a successful third flight test of its DeepStrike JR3 system for the U.S. Army's Joint Reduced Range Rocket program. The company's shares currently trade at $198.58, showing a 30-day return of 2.4% despite a 90-day decline of 11.9%. Longer-term performance remains stronger with a 1-year total shareholder return of 14.8% and a 3-year return of approximately 2.6 times.
Record Backlog
The company's valuation is supported by a record backlog of $289 billion, with Raytheon achieving a rolling 12-month book-to-bill ratio of 1.77. Recent quarterly awards of $19.9 billion for systems including Patriot, AMRAAM, AIM 9X, and LTAMDS indicate strong demand that could translate into revenue and operating profits for years to come.
RTX closed at $198.58 compared with the analyst consensus Narrative on Simply Wall St fair value of about $228.83, which frames the current price against a backdrop of large contracted demand and detailed long term forecasts.
Valuation Debate
While Simply Wall St's analysis suggests RTX is 13.2% undervalued with a fair value of $228.83, the company's P/E ratio tells a different story. RTX trades at 31.9x earnings, higher than the US Aerospace & Defense industry average of 27.1x and above the Simply Wall St fair ratio of 31.6x. This premium valuation leaves less room for error if earnings or defense budgets disappoint.
The RTX story remains sensitive to potential changes in defense budget priorities or supply chain bottlenecks that could slow the conversion of its substantial backlog into actual earnings. Investors must weigh the significant upside potential against these risks as they evaluate the company's current market position.
